Abstract
No public abstract is available from the verified source records.
Heinz Ludwig, Ulrich Wedding, Simon Van Belle
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations
10.1093/annonc/mdn532 · 2009
The illness trajectory of elderly cancer patients across cultures: SIOG position paper
10.1093/annonc/mdl178 · 2007
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
10.1016/j.critrevonc.2005.06.003 · 2005
Participation of patients 65 years of age or older in cancer clinical trials
10.1200/jco.2003.08.010 · 2003
Anemia, cancer, and aging
10.1177/107327480301000606 · 2003
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
10.1016/j.ejca.2004.06.019 · 2004
Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia
10.1182/blood-2004-05-1812 · 2004
Cancer-related anemia: pathogenesis, prevalence and treatment
10.1159/000083128 · 2005
Chemotherapy-induced anemia in adults: incidence and treatment
Confidence 99%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1093/jnci/91.19.1616 · 1999
Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the “Health and Anemia” study
10.1371/journal.pone.0001920 · 2008
Anaemia-related impairment in quality of life in elderly cancer patients prior to chemotherapy
10.1007/s00432-006-0167-8 · 2007
Impact of fatigue on quality of life in oncology patients
10.1016/s0037-1963(00)90063-5 · 2000
Fatigue in an older population
10.1111/j.1532-5415.2000.tb04702.x · 2000
Anemia and cancer in older persons
2007
Mild anemia and the risk of falls in older adults from nursing homes and the community
10.1016/s1525-8610(04)70008-0 · 2004
Fatigue and functional dependence in older cancer patients
10.1097/coc.0b013e31816d915f · 2008
Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated?
10.1046/j.1532-5415.2002.50313.x · 2002
New paradigms for treating elderly patients with cancer: the comprehensive geriatric assessment and guidelines for supportive care
2003
The relationship between psychologic distress and cancer-related fatigue
10.1002/cncr.11463 · 2003
Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy
10.1093/annonc/mdj038 · 2006
Greater risks of chemotherapy toxicity in elderly patients with cancer
2003
Association of comorbidity with disability in older women: the Women's Health and Aging Study
10.1016/s0895-4356(98)00124-3 · 1999
Symptom Management in the Geriatric Patient
10.1177/107327489800503s17 · 1998
Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer
10.1097/jto.0b013e3181c0a128 · 2010
Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy
10.1016/s1040-8428(00)00088-3 · 2001
Management of cancer in the older person: a practical approach
10.1634/theoncologist.5-3-224 · 2000
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
10.1200/jco.2010.29.2201 · 2010
The clinical and economic burden of anemia
2010
Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey
10.1016/j.critrevonc.2009.03.004 · 2009
Age, anemia, and fatigue
10.1053/sonc.2002.33534 · 2002
Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma
10.1002/cncr.21769 · 2006
Anemia in the oncology patient: cognitive function and cancer
10.1097/00002820-200312001-00009 · 2003
Prevalence and management of anaemia in haematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart survey
10.1007/bf03040915 · 2004
The hazards of blood transfusion in historical perspective
10.1182/blood-2008-07-077370 · 2008
Duration of red-cell storage and complications after cardiac surgery
10.1056/nejmoa070403 · 2008
Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature
10.1097/ccm.0b013e3181844677 · 2008
Anemia in cancer patients
1998
Transfusion and lung injury
10.1016/s1246-7820(01)00111-2 · 2001
Relationship between blood transfusion and tumour behaviour
10.1002/bjs.1800781205 · 1991
Aging of the immune system: how much can the adaptive immune system adapt?
10.1016/j.immuni.2006.05.001 · 2006
Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study
10.1016/s0169-5002(99)00098-7 · doi-reference
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial
10.1016/s0169-5002(00)00194-x · doi-reference
Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer
10.1016/s0169-5002(03)00356-8 · doi-reference
Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the “polmone toscano group” (POLTO)
10.1016/j.lungcan.2004.10.008 · doi-reference
Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer
10.1093/jjco/hyi059 · doi-reference
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas
10.1093/annonc/mdl953 · doi-reference
Second-line chemotherapy with a modified schedule of docetaxel in elderly patients with advanced-stage non-small-cell lung cancer
10.3816/clc.2006.n.024 · doi-reference
Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial
10.1097/jto.0b013e318031cd62 · doi-reference
Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer
10.1002/cncr.23583 · doi-reference
Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: an observational study
10.1016/j.critrevonc.2008.06.010 · doi-reference
Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting
10.1016/s1040-8428(02)00132-4 · doi-reference
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
10.1016/s0140-6736(09)60502-x · doi-reference
Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia
10.1200/jco.2008.19.1130 · doi-reference
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes
10.1038/sj.bjc.6605498 · doi-reference
Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy
10.1016/j.critrevonc.2005.06.001 · doi-reference
Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients
10.1016/j.critrevonc.2008.07.010 · doi-reference
September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents
10.1634/theoncologist.13-s3-33 · doi-reference
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update
10.1016/j.ejca.2006.10.014 · doi-reference
Darbepoetin alfa 300 or 500 mug once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
10.1002/ajh.21779 · doi-reference
Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study
10.1038/sj.leu.2404562 · doi-reference
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha
10.1200/jco.2007.12.2051 · doi-reference
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia
10.1200/jco.2010.30.3644 · doi-reference
Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
10.1200/jco.2006.10.4620 · doi-reference
Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy
10.1016/j.ygyno.2009.12.004 · doi-reference
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update
10.1182/blood-2007-08-109488 · doi-reference
Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
10.1634/theoncologist.12-2-231 · doi-reference
Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial
10.1200/jco.2004.08.119 · doi-reference
Iron supplementation during treatment with erythropoiesis-stimulating agents for cancer-related anemia
10.1159/000158539 · doi-reference
Strategies to optimize the use of erythropoietin and iron therapy in oncology patients
10.1111/j.0041-1132.2004.04169.x · doi-reference